Position
ALGERT GLOBAL LLC in Beam Therapeutics Inc.
Back to the book · All holders of BEAM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$134$0.03 → $0.02
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 34.3K | $951 | — | — | — | 0.0% |
| Q1 2026 | 164.3K | $3.92K | $0.02 | −$134 | $3.1K | 0.1% |